Trial intelligence / Profile preview

Ozone vs Dextrose Prolotherapy in Chronic Plantar Fasciitis

NCT05984121Completed

Sponsor
Ahi Evran University Education and Research Hospital
Start
Aug 2023
Primary completion
Dec 2023
Modality
Inhalation Devices
Countries
1
01

Overview

Randomised, open-label trial of medical ozonated water and dextrose in plantar fasciitis (3 arms), sponsored by Ahi Evran University Education and Research Hospital. Primary endpoints: Visual Analogue Scale at 12 weeks and Foot Function Index at 12 weeks. Started Aug 2023; status: completed.

02

Drugs

medical ozonated waterdextrose
03

Conditions

plantar fasciitis

Beyond the preview

Go deeper on NCT05984121.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05984121.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call